5 stories mentioning IRONUpdated 20d ago
Every FINWIRES story that references IRON, newest first.
John D Quisel, Director and Chief Executive Officer, on July 13, 2026, sold 33,000 shares in Disc Medicine (IRON) for $2,473,780. Following the Form 4 filing with the SEC, Quisel has control over a total of 226,064 common shares of the company, with 226,064 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/xslF345X05/ownership.xml
John D Quisel, Director, Chief Executive Officer, on June 18, 2026, sold 34,000 shares in Disc Medicine (IRON) for $2,387,296. Following the Form 4 filing with the SEC, Quisel has control over a total of 226,064 common shares of the company, with 226,064 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/xslF345X05/ownership.xml
Jonathan Yen-Wen Yu, Chief Operating Officer, on June 16, 2026, sold 18,612 shares in Disc Medicine (IRON) for $1,287,801. Following the Form 4 filing with the SEC, Yu has control over a total of 54,324 common shares of the company, with 54,324 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816736/000119312526275996/xslF345X05/ownership.xml
William Jacob Savage, Chief Medical Officer, on April 13, 2026, sold 5,731 shares in Disc Medicine (IRON) for $380,449. Following the Form 4 filing with the SEC, Savage has control over a total of 79,480 common shares of the company, with 79,480 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816736/000119312526157215/xslF345X05/ownership.xml
Jean M. Franchi, Chief Financial Officer, on April 13, 2026, sold 6,657 shares in Disc Medicine (IRON) for $460,834. Following the Form 4 filing with the SEC, Franchi has control over a total of 64,333 common shares of the company, with 64,333 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816736/000119312526157187/xslF345X05/ownership.xml
